Quick Answer
EXAGEN INC. reported Total Assets of $58.02 million for the year ending 2025.
- EXAGEN INC. showed an increase of +29.8% in Total Assets from 2024 to 2025.
- This data is from EXAGEN INC.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2019: $92.74 million | Q1 2020: $84.64 million | Q2 2020: $80.51 million | Q3 2020: $79.99 million | Q1 2021: $137.52 million | Q2 2021: $133.32 million | Q3 2021: $127.77 million | Q1 2022: $122.04 million | Q2 2022: $106.85 million | Q3 2022: $101.60 million | Q1 2023: $79.23 million | Q2 2023: $64.18 million | Q3 2023: $60.93 million | Q1 2024: $50.81 million | Q2 2024: $49.31 million | Q3 2024: $43.61 million | Q1 2025: $40.29 million | Q2 2025: $58.76 million | Q3 2025: $62.82 million.
- Over the full 8 years of available data (2018 to 2025), EXAGEN INC.'s Total Assets has grown by 100.9%.
- Historical annual values: Fiscal year 2025: $58.02 million | Fiscal year 2024: $44.69 million | Fiscal year 2023: $56.94 million | Fiscal year 2022: $86.22 million | Fiscal year 2021: $123.45 million | Fiscal year 2020: $78.38 million | Fiscal year 2019: $88.31 million | Fiscal year 2018: $28.89 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: